Showing results (21-30 of 1,800) with videos related to

Sort By:
Pageof 180
Transplantation and Cellular Therapy|July 13, 2022
Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host DiseaseAlan Bidgoli, Brittany Paige DePriest, Maedeh Vakili Saatloo, et al.
Transplantation and Cellular Therapy|October 9, 2021
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of LifeNisha S Joseph, Vikas A Gupta, Sarah Wyman, et al.
Transplantation and Cellular Therapy|April 7, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012Claudio G Brunstein, Paul V O'Donnell, Brent Logan, et al.
Transplantation and Cellular Therapy|April 10, 2022
Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor DisclosureJasmine Candeliere, Aidan M Kirkham, Risa Shorr, et al.
Transplantation and Cellular Therapy|April 11, 2022
Haploidentical Stem Cell Transplantation After TCR-αβ+ and CD19+ Cells Depletion In Children With Congenital Non-Malignant DiseaseStefano Giardino, Francesca Bagnasco, Michela Falco, et al.
Transplantation and Cellular Therapy|July 19, 2022
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell LymphomasPeter A Riedell, Wei-Ting Hwang, Loretta J Nastoupil, et al.
Transplantation and Cellular Therapy|July 28, 2022
Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive ChemotherapyAmanda C Winters, Grace Bosma, Diana Abbott, et al.
Transplantation and Cellular Therapy|July 28, 2022
Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare EcosystemJane Koo, Jeffrey J Auletta, David M Hartley, et al.
Transplantation and Cellular Therapy|April 17, 2022
Cyclosporine A regulates PMN-MDSCs viability and function through MPTP in acute GVHD: Old medication, new targetXiaoqing Li, Delin Kong, Qiru Yu, et al.
Transplantation and Cellular Therapy|April 22, 2024
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort StudyIvan Pasic, Tommy Alfaro Moya, Mats Remberger, et al.
Pageof 180